GlassScriptPhysician profile
Shimool Rabbani
NPI 1851772073
$3,762.44
in general payments reported to CMS, 2019-2025
29 companies · $1,119 in 2025
The $1,119 reported for 2025 was more than what 86% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $101 · 2021: $83.71 · 2022: $561 · 2023: $939 · 2024: $836 · 2025: $1,119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,789 · Education: $104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,789.09 |
| Education | $104.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $765.54 | 2022-2025 | Tezspire, Breztri, Fasenra |
| Glaxosmithkline, LLC. | $765.42 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $439.73 | 2021-2025 | Ofev, Stiolto Respimat, Jascayd |
| Mylan Specialty L.P. | $290.24 | 2022-2024 | Yupelri |
| Grifols USA, LLC | $189.22 | 2023-2025 | Prolastin-C Liquid |
| Genzyme Corporation | $150.28 | 2022-2025 | |
| Insmed, INC. | $109.50 | 2025 | Arikayce, Brinsupri |
| Amgen INC. | $104.20 | 2023-2025 | Tezspire |
| Philips North America LLC | $101.40 | 2020 | |
| Sanofi-Aventis U.S. LLC | $99.95 | 2024 | |
| Actelion Pharmaceuticals US, INC. | $96.60 | 2022-2025 | Uptravi, Opsumit, Opsynvi |
| Olympus America INC. | $74.10 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $68.97 | 2022-2025 | Dupixent |
| Viatris Specialty LLC | $53.67 | 2025 | Yupelri |
| Verona Pharma, INC. | $50.28 | 2025 | Ohtuvayre |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $48.08 | 2023 | Hillrom - Life 2000 Ventilation System |
| Abbvie INC. | $41.07 | 2024-2025 | |
| Gilead Sciences, INC. | $37.70 | 2022 | |
| Coaptech, INC. | $32.88 | 2025 | Puma System |
| Inspire Medical Systems, INC. | $32.73 | 2025 | Inspire |
| Janssen Pharmaceuticals, INC | $30.58 | 2021 | |
| Harmony Biosciences LLC | $29.96 | 2025 | |
| Ambu INC. | $29.71 | 2024 | |
| Resmed Corp | $27.93 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.20 | 2025 | Glassia |
| Bayer Healthcare Pharmaceuticals INC. | $19.85 | 2024 | |
| La Jolla Pharmaceutical Company | $17.90 | 2024 | Giapreza |
| Merck Sharp & Dohme LLC | $17.70 | 2023 | |
| Electromed, INC. | $15.05 | 2023 | Smartvest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shimool Rabbani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.